Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin

Michael Igel; Katja Arnold; Mikko Niemi; Ute Hofmann; Matthias Schwab; Dieter Luetjohann; Klaus von Bergmann; Michel Eichelbaum; Kari Kivistö

Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin

Michael Igel, Katja Arnold, Mikko Niemi, Ute Hofmann, Matthias Schwab, Dieter Luetjohann, Klaus von Bergmann, Michel Eichelbaum, Kari Kivistö

Research output: Contribution to journal › Article › Scientific › peer-review

104 Citations (Scopus)

Original language	English
Pages (from-to)	419-426
Journal	Clin Pharmacol Ther
Volume	79
Issue number	5
Publication status	Published - 2006
Publication type	A1 Journal article-refereed

Cite this

@article{af950df6598e4c52ad146940ea1a9ec3,

title = "Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin",

author = "Michael Igel and Katja Arnold and Mikko Niemi and Ute Hofmann and Matthias Schwab and Dieter Luetjohann and {von Bergmann}, Klaus and Michel Eichelbaum and Kari Kivist{\"o}",

year = "2006",

language = "English",

volume = "79",

pages = "419--426",

number = "5",

}

TY - JOUR

T1 - Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin

AU - Igel, Michael

AU - Arnold, Katja

AU - Niemi, Mikko

AU - Hofmann, Ute

AU - Schwab, Matthias

AU - Luetjohann, Dieter

AU - von Bergmann, Klaus

AU - Eichelbaum, Michel

AU - Kivistö, Kari

PY - 2006

Y1 - 2006

M3 - Article

VL - 79

SP - 419

EP - 426

JO - Clin Pharmacol Ther

JF - Clin Pharmacol Ther

IS - 5

ER -